Exploring the Potential of Therapeutic Agents Targeted towards Mitigating the Events Associated with Amyloid-β Cascade in Alzheimer’s Disease

One of the most commonly occurring neurodegenerative disorders, Alzheimer’s disease (AD), encompasses the loss of cognitive and memory potential, impaired learning, dementia and behavioral defects, and has been prevalent since the 1900s. The accelerating occurrence of AD is expected to reach 65.7 mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Behl, Tapan, Kaur, Ishnoor, Fratila, Ovidiu, Brata, Roxana, Bungau, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589257/
https://www.ncbi.nlm.nih.gov/pubmed/33050199
http://dx.doi.org/10.3390/ijms21207443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589257/
https://www.ncbi.nlm.nih.gov/pubmed/33050199
http://dx.doi.org/10.3390/ijms21207443

Ejemplares similares